-
Audsley J M., Tannock G A. Cell-Based Influenza Vaccines[J]. Drugs, 2008, 68(11): 1483-1491. doi: 10.2165/00003495-200868110-00002
-
Carrat F, Flahault A. Influenza vaccine: the challenge of antigenic drift[J]. Vaccine, 2007, 25(): 6852-6862. doi: 10.1016/j.vaccine.2007.07.027
-
Chen J M, Guo Y J, Wu K Y. Two pedigree and the origin of influenza B virus evolution[J]. Chin J Virol, 2001, 17(4): 322-327.
-
Govorkova E A, Murti G, Meignier B. African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses[J]. J Virol, 1996, 70(8): 5519-55241.
-
Jackson D, Cadman A, Zurcher T. A reverse genetics approach for recovery of recombinant influenza B viruses entirely from cDNA[J]. J Virol, 2002, 76(): 11744-117471. doi: 10.1128/JVI.76.22.11744-11747.2002
-
Lu J P, Zhou R, Ou Z Y. Isolate the Guangdong strain of influenza B virus and analyzed it's HA gene fragments[J]. Guangdong Med Sci, 2008, 7(29): 1120-1122.
-
Poland G A, Rottinghaus S T, Jacobson R M. Influenza vaccines: a review and rationale for use in developed and underdeveloped countries[J]. Vaccine, 2001, 19(): 2216-2220. doi: 10.1016/S0264-410X(00)00448-5
-
Qi L, Wu K Y, Li X. Screen for high yield influenza B virus in MDCK cells and cloned the whole genome[J]. Chin J Virol, 2004, 20(3): 195-199.
-
Robertson J S. An overview of host cell selection[J]. Dev Biol Stand, 1999, 98(): 7-11.
-
Simonsen L, Taylor R J, Viboud C. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy[J]. Lancet Infectious Disease, 2007, 7(): 658-666. doi: 10.1016/S1473-3099(07)70236-0
-
Wu S H, Shu Y L. The application perspective of the influenza vaccine in Vero cells[J]. Chin J Virol, 2006, 22(1): 70-73.
-
Zhao B X, Li Y, He W Y. Compared two cells strains sensitive to influenza virus[J]. Chin J Disinfec, 2008, 5(25): 463-465.